Burden of disease among patients with prevalent Crohn’s disease: results from a large German sickness fund

por Zhuleku, Evi, Antolin-Fontes, Beatriz, Borsi, Andras, Nissinen, Riikka, Bravatà, Ivana, Barthelmes, Jennifer Norma, Lee, Jennifer, Passey, Alun, Wirth, Daniel, Maywald, Ulf, Bokemeyer, Bernd, Wilke, Thomas, Ghiani, Marco
Publicado 2023

Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn’s Disease patients: A retrospective analysis using German claims data

por Zhuleku, Evi, Antolin-Fontes, Beatriz, Borsi, Andras, Nissinen, Riikka, Bravatà, Ivana, Barthelmes, Jennifer Norma, Le Bars, Manuela, Lee, Jennifer, Passey, Alun, Maywald, Ulf, Deiters, Barthold, Bokemeyer, Bernd, Wilke, Thomas, Ghiani, Marco
Publicado 2022

Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis

por MÄLKÖNEN, Tarja, NUUTINEN, Pauliina, HALLINEN, Taru, SOINI, Erkki, NISSINEN, Riikka, WENNERSTRÖM, Christina, RANTANEN, Tapio, HAGMAN, Johanna H., HARVIMA, Rauno, HÖÖK-NIKANNE, Johanna, ILVES, Tiina, LINTU, Päivi, MALANIN, Ken, SORAMÄKI, Iina, TASANEN, Kaisa, TEHO, Arja, VÄHÄVIHU, Katja, ITÄLINNA, Sari, LEINONEN, Pekka, SARAJÄRVI, Piia, HUILAJA, Laura, PASTERNACK, Rafael
Publicado 2022

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort

por af Björkesten, Clas-Göran, Ilus, Tuire, Hallinen, Taru, Soini, Erkki, Eberl, Anja, Hakala, Kalle, Heikura, Mikko, Jussila, Airi, Koskela, Ritva, Koskinen, Inka, Moilanen, Veikko, Nielsen, Christian, Nieminen, Urpo, Nuutinen, Heikki, Heikkinen, Markku, Suhonen, Ulla-Maija, Tillonen, Jyrki, Utriainen, Karri, Vihriälä, Ilkka, Wennerström, Christina, Borsi, Andras, Nissinen, Riikka, Koivunen, Minni R., Sipponen, Taina
Publicado 2020